表紙:ラテラルフローアッセイの世界市場 (2021-2027年):市場予測 (製品・用途・技術・エンドユーザー別)・COVID-19の影響・地域的展望・用途の潜在性・価格動向・市場シェア
市場調査レポート
商品コード
1035124

ラテラルフローアッセイの世界市場 (2021-2027年):市場予測 (製品・用途・技術・エンドユーザー別)・COVID-19の影響・地域的展望・用途の潜在性・価格動向・市場シェア

Lateral Flow Assays Market Size By Product, By Application, By Technique, By End-use, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 250 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
ラテラルフローアッセイの世界市場 (2021-2027年):市場予測 (製品・用途・技術・エンドユーザー別)・COVID-19の影響・地域的展望・用途の潜在性・価格動向・市場シェア
出版日: 2021年10月29日
発行: Global Market Insights Inc.
ページ情報: 英文 250 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ラテラルフローアッセイの市場は、新型コロナウイルス感染症 (COVID-19) の世界的流行に伴う診断検査へのニーズの高まりから、2027年にかけて堅調なペースで拡大すると予測されています。

また、診断分野における技術の進歩も製品需要を牽引しています。

製品別では、リーダーの部門が2020年に約16億米ドルの規模を示し、予測期間中も堅調な成長を示す見通しです。また、用途別では、乱用薬物検査の部門が予測期間中約6.6%のCAGRで大きく成長すると予測されています。

当レポートでは、世界のラテラルフローアッセイの市場を調査し、市場の定義と概要、COVID-19およびその他の市場影響因子の分析、市場規模の推移・予測、製品・用途・技術・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 ラテラルフローアッセイ産業の考察

  • 産業の分類
  • 産業情勢
  • 産業の影響因子
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性
  • COVID-19:影響分析
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 ラテラルフローアッセイ市場:製品別

  • 主要動向
  • キット
  • リーダー

第5章 ラテラルフローアッセイ市場:用途別

  • 主要動向
  • 感染症検査
    • インフルエンザ
    • 性感染症(STD)
    • 肝炎
    • 結核
    • その他
  • 心臓マーカー検査
    • クレアチンキナーゼ-MB(CK-MB)
    • ミオグロビン
    • D-ダイマー
    • その他
  • 妊娠・受胎能検査
    • 妊娠検査
    • 受胎能検査
  • コレステロール検査
  • 薬物乱用(DoA)検査
  • その他

第6章 ラテラルフローアッセイ市場:技術別

  • 主要動向
  • サンドイッチアッセイ
  • 競合アッセイ
  • マルチプレックス検出アッセイ

第7章 ラテラルフローアッセイ市場:エンドユーザー別

  • 主要動向
  • 病院・クリニック
  • 診断ラボ
  • 在宅医療
  • その他

第8章 ラテラルフローアッセイ市場:地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 企業プロファイル

  • 競合ダッシュボード
  • Abingdon Health
  • Abbott
  • Bio-Rad Laboratories
  • Bioeasy Biotechnology Inc
  • BioMerieux.
  • Hologic's Inc
  • F. Hoffmann La Roche
  • Thermo Fischer Scientific
  • OPERON
  • Quidel Corporation
図表

Data Tables

  • TABLE 1 Global lateral flow assays market, 2016 - 2020 (USD Million)
  • TABLE 2 Global lateral flow assays market, 2021 - 2027 (USD Million)
  • TABLE 3 Global lateral flow assays market, by product, 2016 - 2020 (USD Million)
  • TABLE 4 Global lateral flow assays market, by product, 2021 - 2027 (USD Million)
  • TABLE 5 Global lateral flow assays market, by application, 2016 - 2020 (USD Million)
  • TABLE 6 Global lateral flow assays market, by application, 2021 - 2027 (USD Million)
  • TABLE 7 Global lateral flow assays market, by technique, 2016 - 2020 (USD Million)
  • TABLE 8 Global lateral flow assays market, by technique, 2021 - 2027 (USD Million)
  • TABLE 9 Global lateral flow assays market, by end-use, 2016 - 2020 (USD Million)
  • TABLE 10 Global lateral flow assays market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 11 Global lateral flow assays market, by region, 2016 - 2020 (USD Million)
  • TABLE 12 Global lateral flow assays market, by region, 2021 - 2027 (USD Million)
  • TABLE 13 Industry impact forces
  • TABLE 14 Kits market size, by region, 2016 - 2020 (USD Million)
  • TABLE 15 Kits market size, by region, 2021 - 2027 (USD Million)
  • TABLE 16 Reader market size, by region, 2016 - 2020 (USD Million)
  • TABLE 17 Reader market size, by region, 2021 - 2027 (USD Million)
  • TABLE 18 Infectious disease testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 19 Infectious disease testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 20 Influenza market size, by region, 2016 - 2020 (USD Million)
  • TABLE 21 Influenza market size, by region, 2021 - 2027 (USD Million)
  • TABLE 22 STDs market size, by region, 2016 - 2020 (USD Million)
  • TABLE 23 STDs market size, by region, 2021 - 2027 (USD Million)
  • TABLE 24 Hepatitis market size, by region, 2016 - 2020 (USD Million)
  • TABLE 25 Hepatitis market size, by region, 2021 - 2027 (USD Million)
  • TABLE 26 Tuberculosis market size, by region, 2016 - 2020 (USD Million)
  • TABLE 27 Tuberculosis market size, by region, 2021 - 2027 (USD Million)
  • TABLE 28 Other market size, by region, 2016 - 2020 (USD Million)
  • TABLE 29 Other market size, by region, 2021 - 2027 (USD Million)
  • TABLE 30 Cardiac marker testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 31 Cardiac marker testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 32 CK-MB market size, by region, 2016 - 2020 (USD Million)
  • TABLE 33 CK-MB market size, by region, 2021 - 2027 (USD Million)
  • TABLE 34 Myoglobin market size, by region, 2016 - 2020 (USD Million)
  • TABLE 35 Myoglobin market size, by region, 2021 - 2027 (USD Million)
  • TABLE 36 D-dimer market size, by region, 2016 - 2020 (USD Million)
  • TABLE 37 D-dimer market size, by region, 2021 - 2027 (USD Million)
  • TABLE 38 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 39 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 40 Pregnancy and fertility testing size, by region, 2016 - 2020 (USD Million)
  • TABLE 41 Pregnancy and fertility testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 42 Pregnancy testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 43 Pregnancy testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 44 Fertility testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 45 Fertility testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 46 Cholesterol testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 47 Cholesterol testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 48 Drug-of-Abuse testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 49 Drug-of-Abuse testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 50 Other products market size, by region, 2016 - 2020 (USD Million)
  • TABLE 51 Other products market size, by region, 2021 - 2027 (USD Million)
  • TABLE 52 Sandwich assays market size, by region, 2016 - 2020 (USD Million)
  • TABLE 53 Sandwich assays market size, by region, 2021 - 2027 (USD Million)
  • TABLE 54 Competitive assays market size, by region, 2016 - 2020 (USD Million)
  • TABLE 55 Competitive assays market size, by region, 2021 - 2027 (USD Million)
  • TABLE 56 Multiplex detection assays market size, by region, 2016 - 2020 (USD Million)
  • TABLE 57 Multiplex detection assays market size, by region, 2021 - 2027 (USD Million)
  • TABLE 58 Hospital & clinics market size, by region, 2016 - 2020 (USD Million)
  • TABLE 59 Hospital & clinics market size, by region, 2021 - 2027 (USD Million)
  • TABLE 60 Diagnostic laboratories market size, by region, 2016 - 2020 (USD Million)
  • TABLE 61 Diagnostic laboratories market size, by region, 2021 - 2027 (USD Million)
  • TABLE 62 Homecare settings market size, by region, 2016 - 2020 (USD Million)
  • TABLE 63 Homecare settings market size, by region, 2021 - 2027 (USD Million)
  • TABLE 64 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 65 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 66 North America lateral flow assays market size, by country, 2016 - 2020 (USD Million)
  • TABLE 67 North America lateral flow assays market size, by country, 2021 - 2027 (USD Million)
  • TABLE 68 North America lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 69 North America lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 70 North America lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 71 North America lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 72 North America lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 73 North America lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 74 North America lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 75 North America lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 76 North America lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 77 North America lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 78 North America lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 79 North America lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 80 North America lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 81 North America lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 82 U.S. lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 83 U.S. lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 84 U.S. lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 85 U.S. lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 86 U.S. lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 87 U.S. lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 88 U.S. lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 89 U.S. lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 90 U.S. lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 91 U.S. lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 92 U.S. lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 93 U.S. lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 94 U.S. lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 95 U.S. lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 96 Canada lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 97 Canada lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 98 Canada lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 99 Canada lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 100 Canada lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 101 Canada lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 102 Canada lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 103 Canada lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 104 Canada lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 105 Canada lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 106 Canada lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 107 Canada lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 108 Canada lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 109 Canada lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 110 Europe lateral flow assays market size, by country, 2016 - 2020 (USD Million)
  • TABLE 111 Europe lateral flow assays market size, by country, 2021 - 2027 (USD Million)
  • TABLE 112 Europe lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 113 Europe lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 114 Europe lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 115 Europe lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 116 Europe lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 117 Europe lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 118 Europe lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 119 Europe lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 120 Europe lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 121 Europe lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 122 Europe lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 123 Europe lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 124 Europe lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 125 Europe lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 126 Germany lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 127 Germany lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 128 Germany lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 129 Germany lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 130 Germany lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 131 Germany lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 132 Germany lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 133 Germany lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 134 Germany lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 135 Germany lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 136 Germany lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 137 Germany lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 138 Germany lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 139 Germany lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 140 UK lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 141 UK lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 142 UK lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 143 UK lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 144 UK lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 145 UK lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 146 UK lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 147 UK lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 148 UK lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 149 UK lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 150 UK lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 151 UK lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 152 UK lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 153 UK lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 154 France lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 155 France lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 156 France lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 157 France lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 158 France lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 159 France lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 160 France lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 161 France lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 162 France lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 163 France lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 164 France lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 165 France lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 166 France lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 167 France lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 168 Italy lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 169 Italy lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 170 Italy lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 171 Italy lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 172 Italy lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 173 Italy lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 174 Italy lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 175 Italy lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 176 Italy lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 177 Italy lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 178 Italy lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 179 Italy lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 180 Italy lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 181 Italy lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 182 Spain lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 183 Spain lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 184 Spain lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 185 Spain lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 186 Spain lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 187 Spain lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 188 Spain lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 189 Spain lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 190 Spain lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 191 Spain lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 192 Spain lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 193 Spain lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 194 Spain lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 195 Spain lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 196 Asia Pacific lateral flow assays market size, by country, 2016 - 2020 (USD Million)
  • TABLE 197 Asia Pacific lateral flow assays market size, by country, 2021 - 2027 (USD Million)
  • TABLE 198 Asia Pacific lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 199 Asia Pacific lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 200 Asia Pacific lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 201 Asia Pacific lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 202 Asia Pacific lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 203 Asia Pacific lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 204 Asia Pacific lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 205 Asia Pacific lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 206 Asia Pacific lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 207 Asia Pacific lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 208 Asia Pacific lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 209 Asia Pacific lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 210 Asia Pacific lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 211 Asia Pacific lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 212 China lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 213 China lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 214 China lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 215 China lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 216 China lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 217 China lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 218 China lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 219 China lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 220 China lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 221 China lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 222 China lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 223 China lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 224 China lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 225 China lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 226 India lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 227 India lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 228 India lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 229 India lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 230 India lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 231 India lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 232 India lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 233 India lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 234 India lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 235 India lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 236 India lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 237 India lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 238 India lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 239 India lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 240 Japan lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 241 Japan lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 242 Japan lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 243 Japan lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 244 Japan lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 245 Japan lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 246 Japan lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 247 Japan lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 248 Japan lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 249 Japan lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 250 Japan lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 251 Japan lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 252 Japan lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 253 Japan lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 254 Australia lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 255 Australia lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 256 Australia lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 257 Australia lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 258 Australia lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 259 Australia lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 260 Australia lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 261 Australia lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 262 Australia lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 263 Australia lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 264 Australia lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 265 Australia lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 266 Australia lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 267 Australia lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 268 Latin America lateral flow assays market size, by country, 2016 - 2020 (USD Million)
  • TABLE 269 Latin America lateral flow assays market size, by country, 2021 - 2027 (USD Million)
  • TABLE 270 Latin America lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 271 Latin America lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 272 Latin America lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 273 Latin America lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 274 Latin America lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 275 Latin America lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 276 Latin America lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 277 Latin America lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 278 Latin America lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 279 Latin America lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 280 Latin America lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 281 Latin America lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 282 Latin America lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 283 Latin America lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 284 Brazil lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 285 Brazil lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 286 Brazil lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 287 Brazil lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 288 Brazil lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 289 Brazil lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 290 Brazil lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 291 Brazil lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 292 Brazil lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 293 Brazil lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 294 Brazil lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 295 Brazil lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 296 Brazil lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 297 Brazil lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 298 Mexico lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 299 Mexico lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 300 Mexico lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 301 Mexico lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 302 Mexico lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 303 Mexico lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 304 Mexico lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 305 Mexico lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 306 Mexico lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 307 Mexico lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 308 Mexico lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 309 Mexico lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 310 Mexico lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 311 Mexico lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 312 MEA lateral flow assays market size, by country, 2016 - 2020 (USD Million)
  • TABLE 313 MEA lateral flow assays market size, by country, 2021 - 2027 (USD Million)
  • TABLE 314 MEA lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 315 MEA lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 316 MEA lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 317 MEA lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 318 MEA lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 319 MEA lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 320 MEA lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 321 MEA lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 322 MEA lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 323 MEA lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 324 MEA lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 325 MEA lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 326 MEA lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 327 MEA lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 328 South Africa lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 329 South Africa lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 330 South Africa lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 331 South Africa lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 332 South Africa lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 333 South Africa lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 334 South Africa lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 335 South Africa lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 336 South Africa lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 337 South Africa lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 338 South Africa lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 339 South Africa lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 340 South Africa lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 341 South Africa lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 342 Saudi Arabia lateral flow assays market size, by product, 2016 - 2020 (USD Million)
  • TABLE 343 Saudi Arabia lateral flow assays market size, by product, 2021 - 2027 (USD Million)
  • TABLE 344 Saudi Arabia lateral flow assays market size, by application, 2016 - 2020 (USD Million)
  • TABLE 345 Saudi Arabia lateral flow assays market size, by application, 2021 - 2027 (USD Million)
  • TABLE 346 Saudi Arabia lateral flow assays market size, by infectious disease testing, 2016 - 2020 (USD Million)
  • TABLE 347 Saudi Arabia lateral flow assays market size, by infectious disease testing, 2021 - 2027 (USD Million)
  • TABLE 348 Saudi Arabia lateral flow assays market size, by cardiac marker testing, 2016 - 2020 (USD Million)
  • TABLE 349 Saudi Arabia lateral flow assays market size, by cardiac marker testing, 2021 - 2027 (USD Million)
  • TABLE 350 Saudi Arabia lateral flow assays market size, by pregnancy and fertility testing, 2016 - 2020 (USD Million)
  • TABLE 351 Saudi Arabia lateral flow assays market size, by pregnancy and fertility testing, 2021 - 2027 (USD Million)
  • TABLE 352 Saudi Arabia lateral flow assays market size, by technique, 2016 - 2020 (USD Million)
  • TABLE 353 Saudi Arabia lateral flow assays market size, by technique, 2021 - 2027 (USD Million)
  • TABLE 354 Saudi Arabia lateral flow assays market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 355 Saudi Arabia lateral flow assays market size, by end-use, 2021 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Lateral flow assays industry 360 degree synopsis
  • FIG. 4 Industry segmentation
  • FIG. 5 Global lateral flow assays market, 2016 - 2027 (USD Million)
  • FIG. 6 Growth potential analysis, by product
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Growth potential analysis, by technique
  • FIG. 9 Growth potential analysis, by end-use
  • FIG. 10 Porter's analysis
  • FIG. 11 Company matrix analysis, 2020
  • FIG. 12 PESTEL analysis
  • FIG. 13 Key segment trends, by product
  • FIG. 14 Key segment trends, by application
  • FIG. 15 Key segment trends, by technique
  • FIG. 16 Key segment trends, by end-use
  • FIG. 17 Key regional trends
  • FIG. 18 Competitive dashboard
目次
Product Code: 5147

The lateral flow assays market is set to expand at a robust pace by 2027 owing to burgeoning need for diagnostic testing during the COVID-19 pandemic across the globe.

Lateral flow assays (LFA) are simple paper-based devices designed to detect a target analyte's presence (or absence) in a liquid sample without the need for specialized and expensive equipment. These tests are typically used for medical diagnostics for point of care testing or home testing, or in laboratory settings. Latest technological advancements in diagnostics have driven product demand in recent years.

Notably, industry players are employing lucrative strategies to accommodate the surging demand for infectious disease testing due to the ongoing COVID-19 pandemic, strengthening the overall business outlook.

For instance, in April 2020, Abingdon Health, a leading manufacturer of high-quality rapid lateral flow tests, announced the acquisition of UK-based Concepta plc's lateral flow manufacturing facility based in Doncaster. The deal enabled Abingdon to expand its lateral flow manufacturing presence with the integration of Concepta's manufacturing facility, which is equipped with a fully automated lateral flow manufacturing capacity, including automated cartridge assembly, reel-to-reel spraying, and lamination.

The lateral flow assays market has been segmented on the basis of technique, product, end-use, application, and region. In terms of product, the market has further been divided into readers and kits. The readers sub-segment attained a sizable valuation of nearly USD 1.6 billion in 2020 and is expected to witness steady expansion over the assessment period.

With respect to application, the market has been categorized into drug of abuse testing, infectious disease, cholesterol testing, cardiac marker testing, pregnancy & fertility testing, and others. The drug of abuse testing sub-segment is slated to register considerable growth at a CAGR of about 6.6% through the forecast timeline.

From the technique point of view, the lateral flow assays market has been classified into multiplex detection assays, sandwich assays, and competitive assays. In 2020, the competitive assays sub-segment accounted for a market share of around 33.4% and is speculated to garner notable gains over the analysis period.

Based on end-use, the market has been segregated into homecare settings, diagnostic laboratories, hospitals & clinics, and others. The lateral flow assays industry from the homecare settings sub-segment is foreseen to reach a valuation of more than USD 3.6 billion by 2027.

From the regional spectrum, the Latin America lateral flow assays market held over 5.1% market share in 2020 and is estimated to showcase optimistic growth over 2021-2027. Meanwhile, the Middle East & Africa lateral flow assays industry is anticipated to gain significant traction at almost 5.4% CAGR over the review period.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data Sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Lateral flow assays industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 Technique trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Lateral Flow Assays Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing prevalence of infectious disease
      • 3.3.1.2 Growing demand for point-of-care testing
      • 3.3.1.3 Technological advancements
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Low accuracy of results
      • 3.3.2.2 Availability of substitute product
      • 3.3.2.3 Stringent regulatory framework
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By application
    • 3.4.3 By technique
    • 3.4.4 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2020
    • 3.7.1 Company matrix analysis
  • 3.8 PESTEL analysis

Chapter 4 Lateral Flow Assays Market, By Product

  • 4.1 Key segment trends
  • 4.2 Kits
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Readers
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Lateral Flow Assays Market, By Application

  • 5.1 Key segment trends
  • 5.2 Infectious disease testing
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.2 Influenza
      • 5.2.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.3 Sexually transmitted disease (STD)
      • 5.2.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.4 Hepatitis
      • 5.2.4.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.5 Tuberculosis
      • 5.2.5.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.6 Others
      • 5.2.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Cardiac marker testing
    • 5.3.1 Creatine kinase-MB (CK-MB)
      • 5.3.1.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.3.2 Myoglobin
      • 5.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.3.3 D-dimer
      • 5.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.3.4 Others
      • 5.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Pregnancy and fertility testing
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.4.2 Pregnancy testing
      • 5.4.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.4.3 Fertility testing
      • 5.4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.5 Cholesterol testing
    • 5.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.6 Drug-of-Abuse (DoA) testing
    • 5.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.7 Other products
    • 5.7.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Lateral Flow Assays Market, By Technique

  • 6.1 Key segment trend
  • 6.2 Sandwich assays
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Competitive assays
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.4 Multiplex detection assays
    • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Lateral Flow Assays Market, By End-use

  • 7.1 Key segment trend
  • 7.2 Hospital & clinics
    • 7.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 7.3 Diagnostic laboratories
    • 7.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 7.4 Homecare settings
    • 7.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 7.5 Others
    • 7.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 8 Lateral Flow Assays Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.2.2 Market size, by product, 2016 - 2027 (USD Million)
    • 8.2.3 Market size, by application, 2016 - 2027 (USD Million)
      • 8.2.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
      • 8.2.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
      • 8.2.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
    • 8.2.4 Market size, by technique, 2016 - 2027 (USD Million)
    • 8.2.5 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.2.6 U.S.
      • 8.2.6.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.2.6.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.2.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.2.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.2.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.2.6.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.2.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.2.7 Canada
      • 8.2.7.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.2.7.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.2.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.2.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.2.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.2.7.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.2.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 8.3 Europe
    • 8.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.3.2 Market size, by product, 2016 - 2027 (USD Million)
    • 8.3.3 Market size, by application, 2016 - 2027 (USD Million)
      • 8.3.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
      • 8.3.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
      • 8.3.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
    • 8.3.4 Market size, by technique, 2016 - 2027 (USD Million)
    • 8.3.5 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.3.6 Germany
      • 8.3.6.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.3.6.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.3.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.3.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.3.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.3.6.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.3.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.3.7 UK
      • 8.3.7.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.3.7.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.3.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.3.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.3.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.3.7.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.3.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.3.8 France
      • 8.3.8.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.3.8.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.3.8.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.3.8.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.3.8.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.3.8.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.3.8.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.3.9 Spain
      • 8.3.9.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.3.9.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.3.9.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.3.9.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.3.9.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.3.9.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.3.9.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.3.10 Italy
      • 8.3.10.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.3.10.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.3.10.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.3.10.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.3.10.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.3.10.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.3.10.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.4.2 Market size, by product, 2016 - 2027 (USD Million)
    • 8.4.3 Market size, by application, 2016 - 2027 (USD Million)
      • 8.4.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
      • 8.4.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
      • 8.4.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
    • 8.4.4 Market size, by technique, 2016 - 2027 (USD Million)
    • 8.4.5 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.4.6 China
      • 8.4.6.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.4.6.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.4.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.4.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.4.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.4.6.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.4.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.4.7 Japan
      • 8.4.7.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.4.7.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.4.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.4.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.4.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.4.7.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.4.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.4.8 India
      • 8.4.8.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.4.8.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.4.8.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.4.8.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.4.8.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.4.8.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.4.8.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.4.9 Australia
      • 8.4.9.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.4.9.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.4.9.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.4.9.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.4.9.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.4.9.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.4.9.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.5.2 Market size, by product, 2016 - 2027 (USD Million)
    • 8.5.3 Market size, by application, 2016 - 2027 (USD Million)
      • 8.5.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
      • 8.5.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
      • 8.5.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
    • 8.5.4 Market size, by technique, 2016 - 2027 (USD Million)
    • 8.5.5 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.5.6 Brazil
      • 8.5.6.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.5.6.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.5.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.5.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.5.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.5.6.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.5.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.5.7 Mexico
      • 8.5.7.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.5.7.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.5.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.5.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.5.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.5.7.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.5.7.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 8.6 Middle East and Africa
    • 8.6.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.6.2 Market size, by product, 2016 - 2027 (USD Million)
    • 8.6.3 Market size, by application, 2016 - 2027 (USD Million)
      • 8.6.3.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
      • 8.6.3.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
      • 8.6.3.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
    • 8.6.4 Market size, by technique, 2016 - 2027 (USD Million)
    • 8.6.5 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.6.6 South Africa
      • 8.6.6.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.6.6.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.6.6.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.6.6.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.6.6.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.6.6.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.6.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 8.6.7 Saudi Arabia
      • 8.6.7.1 Market size, by product, 2016 - 2027 (USD Million)
      • 8.6.7.2 Market size, by application, 2016 - 2027 (USD Million)
        • 8.6.7.2.1 Market size, by infectious disease testing, 2016 - 2027 (USD Million)
        • 8.6.7.2.2 Market size, by cardiac marker testing, 2016 - 2027 (USD Million)
        • 8.6.7.2.3 Market size, by pregnancy and fertility testing, 2016 - 2027 (USD Million)
      • 8.6.7.3 Market size, by technique, 2016 - 2027 (USD Million)
      • 8.6.7.4 Market size, by end-use, 2016 - 2027 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Competitive dashboard
  • 9.2 Abingdon Health
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Abbott
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Bio-Rad Laboratories
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Bioeasy Biotechnology Inc
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 BioMerieux.
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Hologic's Inc
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 F. Hoffmann La Roche
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 Thermo Fischer Scientific
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 OPERON
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 Quidel Corporation
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis